Nuzenio

Companion Diagnostic Supporting

Companion Diagnostic Supporting news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 11 publisher sources 100/100 entity strength

Latest news

FDA Approves Labcorp's PGDx Elio Tissue Complete CDx for Advanced Melanoma - Dermatology TimesDermatology Times · Mon, 10 Aug 2026 15:10:24 GMT Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma - PR NewswirePR Newswire · Mon, 10 Aug 2026 11:00:00 GMT For advanced melanoma, Labcorp's test supports access to targeted therapies - Stock TitanStock Titan · Mon, 10 Aug 2026 11:00:00 GMT CellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing ChemistManufacturing Chemist · Fri, 07 Aug 2026 11:00:39 GMT CellCarta Adds Tempus to CDx Commercialization Lab Network - SahmSahm · Thu, 06 Aug 2026 07:00:00 GMT SOPHiA GENETICS and AstraZeneca Collaborate to Develop Oncology Companion Diagnostics - Clinical Lab ProductsClinical Lab Products · Wed, 05 Aug 2026 20:52:25 GMT Labcorp Test May Identify Prostate Cancer Patients for TRUQAP - Stock TitanStock Titan · Tue, 04 Aug 2026 11:00:00 GMT SOPHiA GENETICS partners with AstraZeneca to de... - PluangPluang · Tue, 04 Aug 2026 10:54:46 GMT

Timeline

Mon, 10 Aug 2026 15:10:24 GMTFDA Approves Labcorp's PGDx Elio Tissue Complete CDx for Advanced Melanoma - Dermatology Times

Mon, 10 Aug 2026 11:00:00 GMTLabcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma - PR Newswire

Mon, 10 Aug 2026 11:00:00 GMTFor advanced melanoma, Labcorp's test supports access to targeted therapies - Stock Titan

Fri, 07 Aug 2026 11:00:39 GMTCellCarta adds Tempus to companion diagnostic commercialisation network - Manufacturing Chemist

Thu, 06 Aug 2026 07:00:00 GMTCellCarta Adds Tempus to CDx Commercialization Lab Network - Sahm

Wed, 05 Aug 2026 20:52:25 GMTSOPHiA GENETICS and AstraZeneca Collaborate to Develop Oncology Companion Diagnostics - Clinical Lab Products

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Patients3 live mentions Tempus3 live mentions SOPHiA GENETICS3 live mentions Grand View Research3 live mentions Future Market Insights3 live mentions PGDx Elio Tissue2 live mentions Complete CDx2 live mentions Advanced Melanoma2 live mentions Labcorp2 live mentions CDx Commercialization Lab2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Companion Diagnostic Supporting.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.